Shortness Of Breath Questionnaire Validation Study

NCT00411372 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped No subjects enrolled. Study was canceled before active

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: fluticasone propionate/salmeterol 250/50mcg combination, salmeterol 50mcg

Sponsor

GlaxoSmithKline